InflaRx Closes Funding to Move Its Complement Antibody Program into Clinical Trials for Sepsis Treatment
JENA, Germany--(BUSINESS WIRE)--InflaRx announced today the closing of its funding, led by Affentranger Associates alongside bm-t (beteiligungsmanagement thüringen gmbh).